Efficacy of probiotics for infants with congenital heart disease
Not Applicable
Suspended
- Conditions
- Patients scheduled for pediatric cardiovascular surgery
- Registration Number
- JPRN-UMIN000007143
- Lead Sponsor
- Department of Anesthesiology, Kyoto prefectural university of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
-A subject whose operation is cancelled. -A subject who is not suitable for the trial defined by the attending researcher.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie probiotic efficacy in infants with congenital heart disease?
How do probiotics compare to standard-of-care in preoperative outcomes for pediatric cardiovascular surgery patients?
Which biomarkers correlate with probiotic response in congenital heart disease populations?
What adverse events are associated with probiotic administration in infants undergoing heart surgery?
Are there synergistic effects of combining probiotics with prebiotics in congenital heart disease management?